Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$768K Buy
6,381
+105
+2% +$12.1K 0.17% 98
2025
Q4
$661K Sell
6,276
-73
-1% -$6.85K 0.15% 104
2025
Q3
$533K Buy
6,349
+333
+6% +$27.4K 0.12% 120
2025
Q2
$476K Buy
6,016
+488
+9% +$38.8K 0.12% 127
2025
Q1
$496K Sell
5,528
-147
-3% -$13.7K 0.14% 111
2024
Q4
$565K Sell
5,675
-186
-3% -$19.2K 0.16% 96
2024
Q3
$666K Sell
5,861
-385
-6% -$45.7K 0.18% 88
2024
Q2
$773K Buy
6,246
+331
+6% +$42.6K 0.25% 76
2024
Q1
$780K Hold
5,915
0.27% 70
2023
Q4
$645K Buy
5,915
+1,047
+22% +$109K 0.25% 74
2023
Q3
$501K Sell
4,868
-8
-0.2% -$862 0.23% 79
2023
Q2
$563K Sell
4,876
-347
-7% -$39.4K 0.28% 73
2023
Q1
$556K Sell
5,223
-272
-5% -$29.4K 0.31% 71
2022
Q4
$610K Sell
5,495
-724
-12% -$74K 0.36% 59
2022
Q3
$536K Buy
6,219
+42
+0.7% +$3.75K 0.33% 61
2022
Q2
$563K Buy
6,177
+330
+6% +$29.3K 0.34% 62
2022
Q1
$480K Buy
5,847
+1,054
+22% +$83.1K 0.26% 75
2021
Q4
$367K Buy
4,793
+2,699
+129% +$215K 0.23% 78
2021
Q3
$157K Buy
2,094
+10
+0.5% +$761 0.13% 95
2021
Q2
$162K Buy
+2,084
New +$155K 0.13% 96
2020
Q4
$188K Buy
+2,404
New +$184K 0.18% 79

Other funds holding MRK

Addison Advisors's MRK Position: Q1 2026 in Review

Addison Advisors increased its Merck (MRK) stake by 1.7% in Q1 2026, buying an estimated $12.1K and bringing the position to 6,381 shares worth $768K. The position accounts for 0.17% of the portfolio, ranked #98.

Addison Advisors first reported a position in MRK in Q4 2020 and has held it in 21 quarters since. The position peaked at $780K in Q1 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Addison Advisors held 6,381 shares of Merck worth $768K as of Q1 2026.
  • Addison Advisors bought 105 Merck shares in Q1 2026, an estimated $12.1K.
  • Merck made up 0.17% of Addison Advisors's portfolio in Q1 2026, its #98 holding.
  • Addison Advisors first reported a position in Merck in Q4 2020 and has held it in 21 quarters since.
  • Addison Advisors's Merck position peaked at $780K in Q1 2024.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Addison Advisors's 13F filing for Q1 2026, filed 8 May 2026.